<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2020-10-07" version="207">
<accession>P51692</accession>
<accession>Q8WWS8</accession>
<name>STA5B_HUMAN</name>
<protein>
<recommendedName>
<fullName>Signal transducer and activator of transcription 5B</fullName>
</recommendedName>
</protein>
<gene>
<name type="primary">STAT5B</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Mol. Endocrinol." volume="10" first="508" last="518">
<title>Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone.</title>
<authorList>
<person name="Silva C.M."/>
<person name="Lu H."/>
<person name="Day R.N."/>
</authorList>
<dbReference type="PubMed" id="8732682"/>
<dbReference type="DOI" id="10.1210/mend.10.5.8732682"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="2">
<citation type="submission" date="2003-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Silva C.M."/>
<person name="Lu H."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION TO 628; 717 AND 720</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="10738" last="10744">
<title>Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells.</title>
<authorList>
<person name="Lin J.-X."/>
<person name="Mietz J."/>
<person name="Modi W.S."/>
<person name="John S."/>
<person name="Leonard W.J."/>
</authorList>
<dbReference type="PubMed" id="8631883"/>
<dbReference type="DOI" id="10.1074/jbc.271.18.10738"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2002" name="Gene" volume="285" first="311" last="318">
<title>The structure of human STAT5A and B genes reveals two regions of nearly identical sequence and an alternative tissue specific STAT5B promoter.</title>
<authorList>
<person name="Ambrosio R."/>
<person name="Fimiani G."/>
<person name="Monfregola J."/>
<person name="Sanzari E."/>
<person name="De Felice N."/>
<person name="Salerno M.C."/>
<person name="Pignata C."/>
<person name="D'Urso M."/>
<person name="Ursini M.V."/>
</authorList>
<dbReference type="PubMed" id="12039059"/>
<dbReference type="DOI" id="10.1016/s0378-1119(02)00421-3"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Lymph</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="Eur. J. Biochem." volume="250" first="411" last="417">
<title>Identification of Stat 5B as a substrate of the insulin receptor.</title>
<authorList>
<person name="Sawka-Verhelle D."/>
<person name="Filloux C."/>
<person name="Tartare-Deckert S."/>
<person name="Mothe I."/>
<person name="Van Obberghen E."/>
</authorList>
<dbReference type="PubMed" id="9428692"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1997.0411a.x"/>
</citation>
<scope>PHOSPHORYLATION BY INSR</scope>
<scope>INTERACTION WITH INSR</scope>
<scope>MUTAGENESIS OF THR-684</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1999" name="Cell" volume="96" first="121" last="130">
<title>Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling.</title>
<authorList>
<person name="Zhu M.-H."/>
<person name="John S."/>
<person name="Berg M."/>
<person name="Leonard W.J."/>
</authorList>
<dbReference type="PubMed" id="9989503"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)80965-4"/>
</citation>
<scope>INTERACTION WITH NMI</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="5766" last="5774">
<title>The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells.</title>
<authorList>
<person name="Klejman A."/>
<person name="Schreiner S.J."/>
<person name="Nieborowska-Skorska M."/>
<person name="Slupianek A."/>
<person name="Wilson M."/>
<person name="Smithgall T.E."/>
<person name="Skorski T."/>
</authorList>
<dbReference type="PubMed" id="12411494"/>
<dbReference type="DOI" id="10.1093/emboj/cdf562"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-699</scope>
<scope>MUTAGENESIS OF TYR-699</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="Mol. Endocrinol." volume="16" first="58" last="69">
<title>A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus.</title>
<authorList>
<person name="Aoki N."/>
<person name="Matsuda T."/>
</authorList>
<dbReference type="PubMed" id="11773439"/>
<dbReference type="DOI" id="10.1210/mend.16.1.0761"/>
</citation>
<scope>CAUTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-193</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-193</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-128</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-193</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-90; SER-128 AND SER-193</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2013" name="Mol. Endocrinol." volume="27" first="1982" last="1982">
<title>Retraction.</title>
<authorList>
<person name="Aoki N."/>
<person name="Matsuda T."/>
</authorList>
<dbReference type="PubMed" id="24319783"/>
<dbReference type="DOI" id="10.1210/me.2013-1264"/>
</citation>
<scope>RETRACTION NOTICE OF PUBMED:23186163</scope>
<scope>CAUTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="45340" last="45351">
<title>NCoA-1/SRC-1 is an essential coactivator of STAT5 that binds to the FDL motif in the alpha-helical region of the STAT5 transactivation domain.</title>
<authorList>
<person name="Litterst C.M."/>
<person name="Kliem S."/>
<person name="Marilley D."/>
<person name="Pfitzner E."/>
</authorList>
<dbReference type="PubMed" id="12954634"/>
<dbReference type="DOI" id="10.1074/jbc.m303644200"/>
</citation>
<scope>INTERACTION WITH NCOA1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2004" name="Blood" volume="103" first="1085" last="1088">
<title>FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy.</title>
<authorList>
<person name="Taketani T."/>
<person name="Taki T."/>
<person name="Sugita K."/>
<person name="Furuichi Y."/>
<person name="Ishii E."/>
<person name="Hanada R."/>
<person name="Tsuchida M."/>
<person name="Sugita K."/>
<person name="Ida K."/>
<person name="Hayashi Y."/>
</authorList>
<dbReference type="PubMed" id="14504097"/>
<dbReference type="DOI" id="10.1182/blood-2003-02-0418"/>
</citation>
<scope>PHOSPHORYLATION IN RESPONSE TO FLT3 SIGNALING</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="Cell. Mol. Life Sci." volume="61" first="2535" last="2548">
<title>Signal transduction via the stem cell factor receptor/c-Kit.</title>
<authorList>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="15526160"/>
<dbReference type="DOI" id="10.1007/s00018-004-4189-6"/>
</citation>
<scope>REVIEW ON ROLE IN KIT SIGNALING</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="4557" last="4570">
<title>Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta.</title>
<authorList>
<person name="Kurzer J.H."/>
<person name="Argetsinger L.S."/>
<person name="Zhou Y.J."/>
<person name="Kouadio J.L."/>
<person name="O'Shea J.J."/>
<person name="Carter-Su C."/>
</authorList>
<dbReference type="PubMed" id="15121872"/>
<dbReference type="DOI" id="10.1128/mcb.24.10.4557-4570.2004"/>
</citation>
<scope>PHOSPHORYLATION BY JAK2</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="13817" last="13823">
<title>Suppressor of cytokine signaling 7 inhibits prolactin, growth hormone, and leptin signaling by interacting with STAT5 or STAT3 and attenuating their nuclear translocation.</title>
<authorList>
<person name="Martens N."/>
<person name="Uzan G."/>
<person name="Wery M."/>
<person name="Hooghe R."/>
<person name="Hooghe-Peters E.L."/>
<person name="Gertler A."/>
</authorList>
<dbReference type="PubMed" id="15677474"/>
<dbReference type="DOI" id="10.1074/jbc.m411596200"/>
</citation>
<scope>INTERACTION WITH SOCS7</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="J. Clin. Endocrinol. Metab." volume="90" first="4260" last="4266">
<title>Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b.</title>
<authorList>
<person name="Hwa V."/>
<person name="Little B."/>
<person name="Adiyaman P."/>
<person name="Kofoed E.M."/>
<person name="Pratt K.L."/>
<person name="Ocal G."/>
<person name="Berberoglu M."/>
<person name="Rosenfeld R.G."/>
</authorList>
<dbReference type="PubMed" id="15827093"/>
<dbReference type="DOI" id="10.1210/jc.2005-0515"/>
</citation>
<scope>INVOLVEMENT IN GHII</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="Breast Cancer Res." volume="9" first="R79" last="R79">
<title>Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6.</title>
<authorList>
<person name="Weaver A.M."/>
<person name="Silva C.M."/>
</authorList>
<dbReference type="PubMed" id="17997837"/>
<dbReference type="DOI" id="10.1186/bcr1794"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-699 BY PTK6</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="Mol. Biol. Cell" volume="21" first="3340" last="3351">
<title>ZFP36L1 negatively regulates erythroid differentiation of CD34+ hematopoietic stem cells by interfering with the Stat5b pathway.</title>
<authorList>
<person name="Vignudelli T."/>
<person name="Selmi T."/>
<person name="Martello A."/>
<person name="Parenti S."/>
<person name="Grande A."/>
<person name="Gemelli C."/>
<person name="Zanocco-Marani T."/>
<person name="Ferrari S."/>
</authorList>
<dbReference type="PubMed" id="20702587"/>
<dbReference type="DOI" id="10.1091/mbc.e10-01-0040"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Nucleic Acids Res." volume="38" first="7446" last="7457">
<title>A novel role of CPEB3 in regulating EGFR gene transcription via association with Stat5b in neurons.</title>
<authorList>
<person name="Peng S.C."/>
<person name="Lai Y.T."/>
<person name="Huang H.Y."/>
<person name="Huang H.D."/>
<person name="Huang Y.S."/>
</authorList>
<dbReference type="PubMed" id="20639532"/>
<dbReference type="DOI" id="10.1093/nar/gkq634"/>
</citation>
<scope>INTERACTION WITH CPEB3</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="5956" last="5966">
<title>Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells.</title>
<authorList>
<person name="Chaix A."/>
<person name="Lopez S."/>
<person name="Voisset E."/>
<person name="Gros L."/>
<person name="Dubreuil P."/>
<person name="De Sepulveda P."/>
</authorList>
<dbReference type="PubMed" id="21135090"/>
<dbReference type="DOI" id="10.1074/jbc.m110.182642"/>
</citation>
<scope>PHOSPHORYLATION IN RESPONSE TO KIT SIGNALING</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2003" name="N. Engl. J. Med." volume="349" first="1139" last="1147">
<title>Growth hormone insensitivity associated with a STAT5b mutation.</title>
<authorList>
<person name="Kofoed E.M."/>
<person name="Hwa V."/>
<person name="Little B."/>
<person name="Woods K.A."/>
<person name="Buckway C.K."/>
<person name="Tsubaki J."/>
<person name="Pratt K.L."/>
<person name="Bezrodnik L."/>
<person name="Jasper H."/>
<person name="Tepper A."/>
<person name="Heinrich J.J."/>
<person name="Rosenfeld R.G."/>
</authorList>
<dbReference type="PubMed" id="13679528"/>
<dbReference type="DOI" id="10.1056/nejmoa022926"/>
</citation>
<scope>VARIANT GHII PRO-630</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2012" name="J. Clin. Endocrinol. Metab." volume="97" first="E830" last="839">
<title>A Novel Missense Mutation in the SH2 Domain of the STAT5B Gene Results in a transcriptionally inactive STAT5b associated with severe IGF-I deficiency, immune dysfunction, and lack of pulmonary disease.</title>
<authorList>
<person name="Scaglia P.A."/>
<person name="Martinez A.S."/>
<person name="Feigerlova E."/>
<person name="Bezrodnik L."/>
<person name="Gaillard M.I."/>
<person name="Di Giovanni D."/>
<person name="Ballerini M.G."/>
<person name="Jasper H.G."/>
<person name="Heinrich J.J."/>
<person name="Fang P."/>
<person name="Domene H.M."/>
<person name="Rosenfeld R.G."/>
<person name="Hwa V."/>
</authorList>
<dbReference type="PubMed" id="22419735"/>
<dbReference type="DOI" id="10.1210/jc.2011-2554"/>
</citation>
<scope>VARIANT GHII SER-646</scope>
<scope>CHARACTERIZATION OF VARIANT GHII SER-646</scope>
</reference>
<comment type="function">
<text evidence="22 25">Carries out a dual function: signal transduction and activation of transcription. Mediates cellular responses to the cytokine KITLG/SCF and other growth factors. Binds to the GAS element and activates PRL-induced transcription. Positively regulates hematopoietic/erythroid differentiation.</text>
</comment>
<comment type="subunit">
<text evidence="10 14 18 21 26 27">Forms a homodimer or a heterodimer with a related family member. Binds NR3C1 (By similarity). Interacts with NCOA1 (PubMed:12954634). Interacts with NMI (PubMed:9989503). Interacts with SOCS7 (PubMed:15677474). Interacts (via SH2 domain) with INSR (PubMed:9428692). Interacts with CPEB3; this inhibits STAT5B-mediated transcriptional activation (PubMed:20639532).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-375543">
<id>P00519</id>
<label>ABL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-375077">
<id>P38936</id>
<label>CDKN1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-1020839">
<id>Q13111</id>
<label>CHAF1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-356767">
<id>Q96EY1</id>
<label>DNAJA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-1642515">
<id>I6L957</id>
<label>HNRNPA2B1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-10274069">
<id>Q8TCE9</id>
<label>LGALS14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-2798728">
<id>P61968</id>
<label>LMO4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-394558">
<id>Q71SY5</id>
<label>MED25</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-716172">
<id>P82932</id>
<label>MRPS6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-372942">
<id>Q13287</id>
<label>NMI</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-79893">
<id>Q92569</id>
<label>PIK3R3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-620823">
<id>Q09028</id>
<label>RBBP4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-2652799">
<id>Q99469</id>
<label>STAC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-1186119">
<id>P51692</id>
<label>STAT5B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-3921347">
<id>P51687</id>
<label>SUOX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-3918381">
<id>Q96PN8</id>
<label>TSSK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-743272">
<id>O75604</id>
<label>USP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1186119">
<id>P51692</id>
</interactant>
<interactant intactId="EBI-11741890">
<id>Q86VK4-3</id>
<label>ZNF410</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="10">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="10">Nucleus</location>
</subcellularLocation>
<text evidence="8">Translocated into the nucleus in response to phosphorylation.</text>
</comment>
<comment type="PTM">
<text evidence="13 16 17 20 23 26">Tyrosine phosphorylated in response to signaling via activated KIT, resulting in translocation to the nucleus. Tyrosine phosphorylated in response to signaling via activated FLT3; wild-type FLT3 results in much weaker phosphorylation than constitutively activated mutant FLT3. Alternatively, can be phosphorylated by JAK2. Phosphorylation at Tyr-699 by PTK6 or HCK leads to an increase of its transcriptional activity.</text>
</comment>
<comment type="disease" evidence="15 19 24">
<disease id="DI-01878">
<name>Growth hormone insensitivity with immunodeficiency</name>
<acronym>GHII</acronym>
<description>A disease characterized by short stature, growth hormone deficiency in the presence of normal to elevated circulating concentrations of growth hormone, resistance to exogeneous growth hormone therapy, and recurrent infections.</description>
<dbReference type="MIM" id="245590"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="29">Belongs to the transcription factor STAT family.</text>
</comment>
<comment type="caution">
<text evidence="12 28">It was reported that dephosphorylation on tyrosine residues by PTPN2 would negatively regulate prolactin signaling pathway (PubMed:11773439). However, the corresponding article has been retracted (PubMed:24319783).</text>
</comment>
<comment type="online information" name="STAT5Bbase">
<link uri="http://structure.bmc.lu.se/idbase/STAT5Bbase/"/>
<text>STAT5B mutation db</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/STAT5"/>
<text>STAT5 entry</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/STAT5BID217ch17q21.html"/>
</comment>
<dbReference type="EMBL" id="U48730">
<property type="protein sequence ID" value="AAC50485.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U47686">
<property type="protein sequence ID" value="AAC50491.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ412888">
<property type="protein sequence ID" value="CAD19638.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ412889">
<property type="protein sequence ID" value="CAD19638.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ412890">
<property type="protein sequence ID" value="CAD19638.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ412891">
<property type="protein sequence ID" value="CAD19638.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ412892">
<property type="protein sequence ID" value="CAD19638.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ412893">
<property type="protein sequence ID" value="CAD19638.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ412894">
<property type="protein sequence ID" value="CAD19638.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ412895">
<property type="protein sequence ID" value="CAD19638.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ412896">
<property type="protein sequence ID" value="CAD19638.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ412897">
<property type="protein sequence ID" value="CAD19638.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ412898">
<property type="protein sequence ID" value="CAD19638.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ412899">
<property type="protein sequence ID" value="CAD19638.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC065227">
<property type="protein sequence ID" value="AAH65227.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11423.1"/>
<dbReference type="RefSeq" id="NP_036580.2">
<property type="nucleotide sequence ID" value="NM_012448.3"/>
</dbReference>
<dbReference type="PDB" id="6MBW">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.29"/>
<property type="chains" value="A/B=136-703"/>
</dbReference>
<dbReference type="PDB" id="6MBZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.21"/>
<property type="chains" value="A/B=136-703"/>
</dbReference>
<dbReference type="PDBsum" id="6MBW"/>
<dbReference type="PDBsum" id="6MBZ"/>
<dbReference type="SMR" id="P51692"/>
<dbReference type="BioGRID" id="112654">
<property type="interactions" value="76"/>
</dbReference>
<dbReference type="CORUM" id="P51692"/>
<dbReference type="IntAct" id="P51692">
<property type="interactions" value="117"/>
</dbReference>
<dbReference type="MINT" id="P51692"/>
<dbReference type="STRING" id="9606.ENSP00000293328"/>
<dbReference type="BindingDB" id="P51692"/>
<dbReference type="ChEMBL" id="CHEMBL5817"/>
<dbReference type="DrugBank" id="DB01254">
<property type="generic name" value="Dasatinib"/>
</dbReference>
<dbReference type="iPTMnet" id="P51692"/>
<dbReference type="PhosphoSitePlus" id="P51692"/>
<dbReference type="BioMuta" id="STAT5B"/>
<dbReference type="DMDM" id="41019536"/>
<dbReference type="CPTAC" id="CPTAC-1638"/>
<dbReference type="EPD" id="P51692"/>
<dbReference type="jPOST" id="P51692"/>
<dbReference type="MassIVE" id="P51692"/>
<dbReference type="MaxQB" id="P51692"/>
<dbReference type="PaxDb" id="P51692"/>
<dbReference type="PeptideAtlas" id="P51692"/>
<dbReference type="PRIDE" id="P51692"/>
<dbReference type="ProteomicsDB" id="56378"/>
<dbReference type="Antibodypedia" id="3804">
<property type="antibodies" value="887 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="6777"/>
<dbReference type="Ensembl" id="ENST00000293328">
<property type="protein sequence ID" value="ENSP00000293328"/>
<property type="gene ID" value="ENSG00000173757"/>
</dbReference>
<dbReference type="GeneID" id="6777"/>
<dbReference type="KEGG" id="hsa:6777"/>
<dbReference type="UCSC" id="uc002hzh.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6777"/>
<dbReference type="DisGeNET" id="6777"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000173757.9"/>
<dbReference type="GeneCards" id="STAT5B"/>
<dbReference type="HGNC" id="HGNC:11367">
<property type="gene designation" value="STAT5B"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000173757">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="STAT5B"/>
<dbReference type="MIM" id="245590">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="604260">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P51692"/>
<dbReference type="OpenTargets" id="ENSG00000173757"/>
<dbReference type="Orphanet" id="520">
<property type="disease" value="Acute promyelocytic leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="220465">
<property type="disease" value="Laron syndrome with immunodeficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36186"/>
<dbReference type="eggNOG" id="KOG3667">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00990000203570"/>
<dbReference type="HOGENOM" id="CLU_014189_2_2_1"/>
<dbReference type="InParanoid" id="P51692"/>
<dbReference type="KO" id="K11224"/>
<dbReference type="OMA" id="IWLNRQQ"/>
<dbReference type="OrthoDB" id="327469at2759"/>
<dbReference type="PhylomeDB" id="P51692"/>
<dbReference type="TreeFam" id="TF318648"/>
<dbReference type="PathwayCommons" id="P51692"/>
<dbReference type="Reactome" id="R-HSA-1170546">
<property type="pathway name" value="Prolactin receptor signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1266695">
<property type="pathway name" value="Interleukin-7 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1433557">
<property type="pathway name" value="Signaling by SCF-KIT"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1839117">
<property type="pathway name" value="Signaling by cytosolic FGFR1 fusion mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-186763">
<property type="pathway name" value="Downstream signal transduction"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2586552">
<property type="pathway name" value="Signaling by Leptin"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-512988">
<property type="pathway name" value="Interleukin-3, Interleukin-5 and GM-CSF signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8854691">
<property type="pathway name" value="Interleukin-20 family signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8983432">
<property type="pathway name" value="Interleukin-15 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8985947">
<property type="pathway name" value="Interleukin-9 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9020558">
<property type="pathway name" value="Interleukin-2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9020958">
<property type="pathway name" value="Interleukin-21 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9027283">
<property type="pathway name" value="Erythropoietin activates STAT5"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9645135">
<property type="pathway name" value="STAT5 Activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-982772">
<property type="pathway name" value="Growth hormone receptor signaling"/>
</dbReference>
<dbReference type="SignaLink" id="P51692"/>
<dbReference type="SIGNOR" id="P51692"/>
<dbReference type="BioGRID-ORCS" id="6777">
<property type="hits" value="26 hits in 894 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="STAT5B">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="STAT5B"/>
<dbReference type="GenomeRNAi" id="6777"/>
<dbReference type="Pharos" id="P51692">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P51692"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="RNAct" id="P51692">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000173757">
<property type="expression patterns" value="Expressed in blood and 247 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P51692">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P51692">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0035259">
<property type="term" value="F:glucocorticoid receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046983">
<property type="term" value="F:protein dimerization activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071364">
<property type="term" value="P:cellular response to epidermal growth factor stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071363">
<property type="term" value="P:cellular response to growth factor stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032870">
<property type="term" value="P:cellular response to hormone stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006952">
<property type="term" value="P:defense response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0046543">
<property type="term" value="P:development of secondary female sexual characteristics"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046544">
<property type="term" value="P:development of secondary male sexual characteristics"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007565">
<property type="term" value="P:female pregnancy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060397">
<property type="term" value="P:growth hormone receptor signaling pathway via JAK-STAT"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035723">
<property type="term" value="P:interleukin-15-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038110">
<property type="term" value="P:interleukin-2-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038111">
<property type="term" value="P:interleukin-7-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038113">
<property type="term" value="P:interleukin-9-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007595">
<property type="term" value="P:lactation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019915">
<property type="term" value="P:lipid storage"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001553">
<property type="term" value="P:luteinization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097531">
<property type="term" value="P:mast cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001779">
<property type="term" value="P:natural killer cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045647">
<property type="term" value="P:negative regulation of erythrocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048541">
<property type="term" value="P:Peyer's patch development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042104">
<property type="term" value="P:positive regulation of activated T cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045579">
<property type="term" value="P:positive regulation of B cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045648">
<property type="term" value="P:positive regulation of erythrocyte differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045588">
<property type="term" value="P:positive regulation of gamma-delta T cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032743">
<property type="term" value="P:positive regulation of interleukin-2 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045931">
<property type="term" value="P:positive regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0040018">
<property type="term" value="P:positive regulation of multicellular organism growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032825">
<property type="term" value="P:positive regulation of natural killer cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045954">
<property type="term" value="P:positive regulation of natural killer cell mediated cytotoxicity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032819">
<property type="term" value="P:positive regulation of natural killer cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042448">
<property type="term" value="P:progesterone metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007259">
<property type="term" value="P:receptor signaling pathway via JAK-STAT"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030856">
<property type="term" value="P:regulation of epithelial cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0040014">
<property type="term" value="P:regulation of multicellular organism growth"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019218">
<property type="term" value="P:regulation of steroid metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0032355">
<property type="term" value="P:response to estradiol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070670">
<property type="term" value="P:response to interleukin-4"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043434">
<property type="term" value="P:response to peptide hormone"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0033077">
<property type="term" value="P:T cell differentiation in thymus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043029">
<property type="term" value="P:T cell homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019530">
<property type="term" value="P:taurine metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="CDD" id="cd10420">
<property type="entry name" value="SH2_STAT5b"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.532.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.630">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR008967">
<property type="entry name" value="p53-like_TF_DNA-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001217">
<property type="entry name" value="STAT"/>
</dbReference>
<dbReference type="InterPro" id="IPR035858">
<property type="entry name" value="STAT5a/5b"/>
</dbReference>
<dbReference type="InterPro" id="IPR035886">
<property type="entry name" value="STAT5b_SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036535">
<property type="entry name" value="STAT_N_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013800">
<property type="entry name" value="STAT_TF_alpha"/>
</dbReference>
<dbReference type="InterPro" id="IPR015988">
<property type="entry name" value="STAT_TF_coiled-coil"/>
</dbReference>
<dbReference type="InterPro" id="IPR013801">
<property type="entry name" value="STAT_TF_DNA-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR012345">
<property type="entry name" value="STAT_TF_DNA-bd_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR013799">
<property type="entry name" value="STAT_TF_prot_interaction"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11801">
<property type="entry name" value="PTHR11801"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11801:SF47">
<property type="entry name" value="PTHR11801:SF47"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01017">
<property type="entry name" value="STAT_alpha"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02864">
<property type="entry name" value="STAT_bind"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02865">
<property type="entry name" value="STAT_int"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00252">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00964">
<property type="entry name" value="STAT_int"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47655">
<property type="entry name" value="SSF47655"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48092">
<property type="entry name" value="SSF48092"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49417">
<property type="entry name" value="SSF49417"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0242">Dwarfism</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<feature type="chain" description="Signal transducer and activator of transcription 5B" id="PRO_0000182429">
<location>
<begin position="1"/>
<end position="787"/>
</location>
</feature>
<feature type="domain" description="SH2" evidence="11">
<location>
<begin position="589"/>
<end position="686"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with NMI" evidence="27">
<location>
<begin position="232"/>
<end position="321"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="7">
<location>
<position position="90"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 7">
<location>
<position position="128"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4 6 7">
<location>
<position position="193"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="9">
<location>
<position position="682"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by HCK, JAK and PTK6" evidence="13 20">
<location>
<position position="699"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2277619." id="VAR_052074">
<original>A</original>
<variation>V</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence variant" description="In GHII; affects activation by growth hormone or interferon-gamma; dbSNP:rs121908501." id="VAR_018728" evidence="15">
<original>A</original>
<variation>P</variation>
<location>
<position position="630"/>
</location>
</feature>
<feature type="sequence variant" description="In GHII; transcriptionally inactive." id="VAR_067368" evidence="24">
<original>F</original>
<variation>S</variation>
<location>
<position position="646"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with INSR." evidence="26">
<original>T</original>
<variation>A</variation>
<location>
<position position="684"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation by HCK." evidence="13">
<original>Y</original>
<variation>F</variation>
<location>
<position position="699"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAC50491." ref="2" evidence="29">
<original>A</original>
<variation>P</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="141"/>
<end position="182"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="194"/>
<end position="249"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="251"/>
<end position="262"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="263"/>
<end position="265"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="273"/>
<end position="302"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="309"/>
<end position="330"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="332"/>
<end position="336"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="340"/>
<end position="343"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="347"/>
<end position="354"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="355"/>
<end position="364"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="368"/>
<end position="375"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="376"/>
<end position="383"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="400"/>
<end position="402"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="404"/>
<end position="406"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="407"/>
<end position="410"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="411"/>
<end position="421"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="435"/>
<end position="437"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="440"/>
<end position="449"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="451"/>
<end position="454"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="456"/>
<end position="462"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="468"/>
<end position="471"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="472"/>
<end position="488"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="500"/>
<end position="503"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="504"/>
<end position="519"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="527"/>
<end position="537"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="545"/>
<end position="548"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="552"/>
<end position="554"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="555"/>
<end position="559"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="564"/>
<end position="567"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="569"/>
<end position="583"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="586"/>
<end position="590"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="600"/>
<end position="608"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="614"/>
<end position="619"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="621"/>
<end position="623"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="627"/>
<end position="631"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="636"/>
<end position="638"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="648"/>
<end position="653"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="656"/>
<end position="662"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="668"/>
<end position="672"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="675"/>
<end position="679"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="680"/>
<end position="682"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6MBW"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6MBZ"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250"/>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P42229"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P42232"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11773439"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12411494"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12954634"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="13679528"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14504097"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15121872"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15677474"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15827093"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17997837"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20639532"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20702587"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21135090"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22419735"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8732682"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9428692"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9989503"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="24319783"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000305"/>
<sequence length="787" mass="89866" checksum="AA2F1CAB20955ACA" modified="2004-01-16" version="2">MAVWIQAQQLQGEALHQMQALYGQHFPIEVRHYLSQWIESQAWDSVDLDNPQENIKATQLLEGLVQELQKKAEHQVGEDGFLLKIKLGHYATQLQNTYDRCPMELVRCIRHILYNEQRLVREANNGSSPAGSLADAMSQKHLQINQTFEELRLVTQDTENELKKLQQTQEYFIIQYQESLRIQAQFGPLAQLSPQERLSRETALQQKQVSLEAWLQREAQTLQQYRVELAEKHQKTLQLLRKQQTIILDDELIQWKRRQQLAGNGGPPEGSLDVLQSWCEKLAEIIWQNRQQIRRAEHLCQQLPIPGPVEEMLAEVNATITDIISALVTSTFIIEKQPPQVLKTQTKFAATVRLLVGGKLNVHMNPPQVKATIISEQQAKSLLKNENTRNDYSGEILNNCCVMEYHQATGTLSAHFRNMSLKRIKRSDRRGAESVTEEKFTILFESQFSVGGNELVFQVKTLSLPVVVIVHGSQDNNATATVLWDNAFAEPGRVPFAVPDKVLWPQLCEALNMKFKAEVQSNRGLTKENLVFLAQKLFNNSSSHLEDYSGLSVSWSQFNRENLPGRNYTFWQWFDGVMEVLKKHLKPHWNDGAILGFVNKQQAHDLLINKPDGTFLLRFSDSEIGGITIAWKFDSQERMFWNLMPFTTRDFSIRSLADRLGDLNYLIYVFPDRPKDEVYSKYYTPVPCESATAKAVDGYVKPQIKQVVPEFVNASADAGGGSATYMDQAPSPAVCPQAHYNMYPQNPDSVLDTDGDFDLEDTMDVARRVEELLGRPMDSQWIPHAQS</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

